Laryngeal preservation: What is the best treatment strategy? Ehab Y. Hanna Invited Commentary Pages: 167 - 169
Hepatocellular carcinoma: Epidemic and treatment Jill AllenAlan Venook OriginalPaper Pages: 177 - 183
Novel therapies for pancreatic adenocarcinoma Simona M. PinoHenry Q. XiongJames L. Abbruzzese OriginalPaper Pages: 199 - 206
Complications of androgen deprivation therapy in men with prostate cancer Allen C. ChenDaniel P. Petrylak OriginalPaper Pages: 209 - 215
Artificial neural networks for predictive modeling in prostate cancer Eduard J. GamitoE. David Crawford OriginalPaper Pages: 216 - 221
Targeting osseous metastases: Rationale and development of radioimmunotherapy for prostate cancer Michael J. MorrisNeeta Pandit-TaskarHoward I. Scher OriginalPaper Pages: 222 - 229
Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder Ronald D. Ennis OriginalPaper Pages: 230 - 236
What’s new in the field of prostate cancer chemoprevention? Kanwaljit MahalJavier HernandezIan M. Thompson OriginalPaper Pages: 237 - 242